Data: 08/08/2026
Total encontrado: 9
1/9US=36 / Biol/Mol
Abbas AK, Lichtman AH, Pober JS. Citocinas. In: ___. Imunologia celular e molecular. 4ª ed. Rio de Janeiro: Revinter, 2003. p. 235-269. ISBN 85-7309-642-X.

CITOCINAS. PROPRIEDADES; IMUNIDADE INATA; INTERLEUCINA 1; QUIMIOCINAS; FATOR DE CRESCIMENTO; TRANSFORMACAO; CITOCINAS ESTIMULAM. HEMATOPOIESW

2/9US=102 / Câncer
Beuschlein F. Mouse models of adrenal tumorigenesis. In: Hammer GD, Else T. Adrenocortical carcinoma: basic science and clinical concepts. New York: Springer, 2011. p. 325-40. ISBN 978-0-387-77235-6.

CAMUNDONGOS. EXPERIMENTOS; FATOR DE CRESCIMENTO; TRANSPLANTE; FENOTIPOS; EXPRESSAO TRANSGENICA

3/9US=23-F / Câncer
Finn SP, O'Leary JJ, Sheils OM. Papillary thyroid carcinoma: detection of copy gain of platelet derived growth factor B using array combination with laser capture microdissection. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 387-98. ISBN 978-90-481-3185-3.

CARCINOMA PAPILIFERO DA TIREOIDE; FATOR DE CRESCIMENTO

4/9US=7 / Gastro
Wray CJ, Shah AN, Berman RS, Ahmad SA. Biology of colorectal cancer liver metastases. In: Vauthey JN, Hoff PMG, Audisio RA, Poston GJ. Liver metastases. New York: Springer, 2009. p. 15-24. ISBN 978-1-84628-946-0.

METASTASES HEPATICAS. BIOLOGIA; CANCER COLORRETAL; TRANSICAO EPITELIO-MESENQUIMAL; FATOR DE CRESCIMENTO; ANGIOGENESE; APOPTOSE; TRATAMENTO ANTI-ANGIOGENICO

5/9US=22 / Urologia
Parton M, Das T, Sa G, Finke J, Eisen T, Tannenbaum C. Tumour necrosis factor - misnomer and therapeutic target. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 425-48. ISBN 978-1-58829-737-2.

FATOR DE NECROSE TUMORAL; CITOCINA; IMUNOMODULACAO; ANGIOGENESE; FATOR DE CRESCIMENTO

6/9US=35 / Gastro
Kiguchi K, DiGiovanni J. Role of growth factor-signaling pathways. In: Thomas CR Junior, Fuller CD. Biliary tract and gallbladder cancer: diagnosis and therapy. New Jersey: DemosMedical, 2009. p. 19-34. ISBN 978-1-933864-42-6.

NEOPLASIAS DO TRATO BILIAR; CANCER DE VESICULA BILIAR; FATOR DE CRESCIMENTO; FAMILIA ERBB; RECEPTOR DO FATOR DE CRESCIMENTO INSULIN-LIKE 1; C-MET; MTOR; COX-2

7/9US=28 / Biol/Mol
Hicklin DJ. Vascular endothelial growth factor family and its receptors. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 3-26. ISBN 978-1-58829-870-6.

FACTORES DE CRESCIMENTO ENDOTELIAL VASCULAR; ANGIOGENESE; CANCER; FATOR DE CRESCIMENTO; LIGANTE; NEUROPILINA; RECEPTOR; VEGF

8/9US=84 / Biol/Mol
Jin Q, Gao G, Mulder KM. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: involvement of km23 dynein light chains in TGF B signaling. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 169-84. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3.

KM23; TGF-B; DINEINA; TRANSDUCAO DE SINAL; CANCER; FATOR DE CRESCIMENTO; PROTEINA MOTOR; DYNLRB; SMAD; TRAFICO

9/9US=554 / Tese/FAP
Lima LGCA. Avaliação gênica de isocitrato desidrogenase 1, alfa-internexina, receptor de fator de crescimento epidérmico, O6-metilguanina-DNA metiltransferase e codeleção 1p/19q como fator prognóstico em astrocitomas anaplásicos. [Isocitrate dehydrogenase 1, alpha-internexin, epidermal growth factor receptor, O6-methylguanine-DNA methyltransferase and 1p/19q codeletion as prognostic factors in anaplastic astrocytomas]. São Paulo, 2015. 69 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2015/LuizGCALima/LuizGCALima.pdf

Curriculum Lattes

ASTROCITOMA; PROGNOSTICO; GLIOMA; ISOCITRATO DESIDROGENASE. GENETICA; FATOR DE CRESCIMENTO; EPIDERMICO/GENETICA; IMUNO-HISTOQUIMICA; O(6)-METILGUANINA-DNA METILTRANSFERASE; GENE ERBB-1